Literature DB >> 25214556

Evaluation of passive immunotherapeutic efficacy of hyperimmunized egg yolk powder against intestinal colonization of Campylobacter jejuni in chickens.

Narayan C Paul1, Salma Al-Adwani1, Rocio Crespo1, Devendra H Shah2.   

Abstract

Campylobacter jejuni is a leading cause of foodborne bacterial gastroenteritis in human. Chickens are the reservoir host of C. jejuni, and contaminated chicken meat is an important source of human infection. Therefore, control of C. jejuni in chickens can have direct effect on human health. In this study we tested the passive immunotherapeutic efficacy of the chicken egg-yolk-derived antibodies, in the form of hyperimmunized egg yolk powder (HEYP), against 7 colonization-associated proteins of C. jejuni, namely, CadF (Campylobacter adhesion to fibronectin), FlaA (flagellar proteins), MOMP (major outer membrane protein), FlpA (fibronectin binding protein A), CmeC (Campylobacter multidrug efflux C), Peb1A (Campylobacter putative adhesion), and JlpA (Jejuni lipoprotein A). Three chicken experiments were performed. In each experiment, chickens were treated orally via feed supplemented with 10% (wt/wt) egg yolk powder. In experiment 1, chicken groups were experimentally infected with C. jejuni (10(8) cfu) followed by treatment with 5 HEYP (CadF, FlaA, MOMP, FlpA, CmeC) for 4 d either individually or as a cocktail containing equal parts of each HEYP. In experiment 2, chickens were treated for 21 d with cocktail containing equal parts of 7 HEYP before and after experimental infection with C. jejuni (10(8) cfu). In experiment 3, chickens were treated with feed containing a cocktail of 7 HEYP before and after (prophylaxis), and after (treatment) experimental infection with C. jejuni (10(5) cfu). Intestinal colonization of C. jejuni was monitored by culturing cecal samples from chickens euthanized at the end of each experiment. The results showed that there were no differences in the cecal colonization of C. jejuni between HEYP treated and nontreated control chickens, suggesting that use of HEYP at the dose and the regimens used in the current study is not efficacious in reducing C. jejuni colonization in chickens. ©2014 Poultry Science Association Inc.

Entities:  

Keywords:  Campylobacter jejuni; colonization; hyperimmunized egg yolk powder

Mesh:

Substances:

Year:  2014        PMID: 25214556     DOI: 10.3382/ps.2014-04234

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  5 in total

1.  Production and characterization of anti-Campylobacter jejuni IgY derived from egg yolks.

Authors:  Alexandre Thibodeau; Philippe Fravalo; Audrey Perron; Sylvette Laurent- Lewandowski; Ann Letellier
Journal:  Acta Vet Scand       Date:  2017-12-06       Impact factor: 1.695

2.  In vitro efficacy of potentiated egg yolk powder against Campylobacter jejuni does not correlate with in vitro efficacy.

Authors:  Amina Soumaila Garba; Alexandre Thibodeau; Audrey Perron; Sylvette Laurent-Lewandowski; Ann Letellier; Philippe Fravalo
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

3.  Reducing Campylobacter jejuni colonization in broiler chickens by in-feed supplementation with hyperimmune egg yolk antibodies.

Authors:  Jasmien Vandeputte; An Martel; Stefano Canessa; Nathalie Van Rysselberghe; Lieven De Zutter; Marc Heyndrickx; Freddy Haesebrouck; Frank Pasmans; An Garmyn
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

4.  Engineering the Campylobacter jejuni N-glycan to create an effective chicken vaccine.

Authors:  Harald Nothaft; Brandi Davis; Yee Ying Lock; Maria Elisa Perez-Munoz; Evgeny Vinogradov; Jens Walter; Colin Coros; Christine M Szymanski
Journal:  Sci Rep       Date:  2016-05-25       Impact factor: 4.379

5.  Research Note: Lyophilization of hyperimmune egg yolk: effect on antibody titer and protection of broilers against Campylobacter colonization.

Authors:  Jasmien Vandeputte; An Martel; Gunther Antonissen; Marc Verlinden; Lieven De Zutter; Marc Heyndrickx; Freddy Haesebrouck; Frank Pasmans; An Garmyn
Journal:  Poult Sci       Date:  2020-02-14       Impact factor: 3.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.